We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this episode of Meeting Mic, we bring you Healio’s top headlines from DDW 2023.
Jessica R. Allegretti, MD, MPH, reviews the results of a Tremfya study presented at the meeting. :09
Ken Blount, PhD, discusses restoration of gut microbiota and clonal engraftment after treatment with Rebyota. 4:07
Evan S. Dellon, MD, MPH, explains the improvements of mepolizumab seen in patients with eosinophilic esophagitis. 10:50
Jessica R. Allegretti alsodiscusses the treatment with Rebyota in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection. 15:16
Shrujal Baxi, MD, MPH, describes the use of artificial intelligence for polyp detection for colorectal cancer. 19:26
Paul Limburg, MD, MPH, AGAF, reviews the revised guidelines and the push for non-invasive screening methods for colorectal cancer. 24:07
Disclosures:
Allegretti reports consulting for Ferring Pharmaceuticals and Janssen Biotech. Baxi is chief medical officer of Iterative Scopes. Blount is employed by Ferring Pharmaceuticals and Rebiotix. Dellon reports consulting for and received research funding from GSK. Limburg is chief medical officer for screening at Exact Sciences.
